Market of Mesenchymal Stem Cells Analyzed for Trends, Advances and Applications

PUNE, India, December 16, 2015 /PRNewswire/ --

Market report "Mesenchymal Stem Cells industry Advances & Applications" says that with the first "thaw and use" ink to make MSCs readily available for 3D printing (RoosterBio and CELLINK), a novel manufacturing approach to produce a nearly unlimited supply of MSCs from iPSCs derived from a single donor (Cynata Therapeutics), and the recommendation for approval of a MSC product in Japan (JR-031 developed by Mesoblast's Japanese partner, JCR Pharmaceuticals Co. Ltd), it is clear that the scope of the mesenchymal stem cells industry is expanding and advanced analytics are required.

Complete report Mesenchymal Stem Cells - Advances & Applications spread across 250 pages, analyzing 35 leading competitors and providing in-depth TOC is now available at http://www.rnrmarketresearch.com/mesenchymal-stem-cells-advances-applications-market-report.html.

In addition, the market report describes the current status of mesenchymal stem cells research, ongoing clinical trials involving MSCs, late stage MSC clinical trials, and possible uses of MSCs in cell therapy. Because MSCs are a sub-segment of the broader cell therapy (CT) and regenerative medicine (RM) markets, it also gives an overview of the regenerative medicine industry and overall cell therapy industry.

The report also explores recent advances in MSC products and technologies, identifies research priorities by market segment, and assesses 35 leading competitors within the mesenchymal stem cells marketplace. For pharmaceutical companies, it reveals how advances in MSC research can reveal potential new drug targets, improve methods of drug delivery, and provide personalized treatment strategies.

The selected company profiles analysed by mesenchymal stem cells industry advances & applications report are American Type Culture Collection Inc. (ATCC), Anterogen Co., Ltd., Apceth GmbH & Co. KG, BioCardia Inc., BioRestorative Therapies Inc., Bone Therapeutics SA, BrainStorm Cell Therapeutics Inc., CellGenix Technologie Transfer GmbH, Celprogen Inc., CellTherapies P/L, Cesca Therapeutics Inc., Cyagen Biosciences Inc., Cynata Therapeutics Ltd., Cytori Therapeutics Inc., Escape Therapeutics, Genlantis, Kite Pharma Inc., Life Technologies Corporation, Lonza Group Ltd., Medipost Co. Ltd., Mesoblast Ltd., NuVasive Inc., Ocata Therapeutics Inc., Organogenesis Inc., Orthofix International N.V., Osiris Therapeutics Inc., Pluristem Therapeutics Inc., PromoCell, Regeneus Ltd., ScienCell Research Laboratories, STEMCELL Technologies Inc., Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd., TiGenix N.V. and Vericel Corporation.

The main objectives of the report are to consider the current status of global regenerative medicine (RM) industry in the utilization of stem cells in general and MSCs in particular; current status of global cell therapy (CT) industry, the application of cell therapy in various disease indications, and the total number of clinical trials involving the different types of stem cells; current status of MSCs in clinical trials, the dominance of MSCs in the ongoing clinical trials involving stem cells, the various applications of MSCs in different disease indications, and the number of clinical trials involving MSCs for different disease types. The number of companies involved in the development of MSCs, the clinical trials sponsored by major companies and their ongoing search for MSCs-based cell therapy products. Analysis of traditional market metrics (grant rates, clinical trial rates, patent rates, scientific publication rates) and new social analytics (metrics from social media sites, search engines, Google Trends, and more). Order a copy of Mesenchymal Stem Cells - Advances & Applications report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=58114.

Key findings within this report include: Trend rate data for MSC grants, clinical trials, scientific publications, and patents, Recent advances in MSC research and clinical applications, Market size determinations, including future projections through 2020, Deal-making within the mesenchymal stem cells marketplace, including key acquisitions and partnerships, Competitive assessment of the mesenchymal stem cells marketplace, by market segment, Research priorities by market segment, Top influencers with the mesenchymal stem cells marketplace, Social analytics for the mesenchymal stem cells marketplace, Twitter User Data, Google Trends User Data, Google Adwords Costs, and Hashtag, Overview of the broader regenerative medicine (RM) and cell therapy (CT) marketplace and Company profiles for 35 mesenchymal stem cells industry leaders.

Explore other reports on stem cell market at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/stem-cell.

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com